Nucleate Michigan – MBVF Seminar #1: Kalyan Handique and David Esposito

Join Nucleate Michigan and the Michigan Biomedical Venture Fund (MBVF) for the first seminar in our Fall '26 Lecture Series, a 3-part seminar program that explores what it is to evaluate and build biotech ideas from concept to clinic. Speakers will provide experiential expertise and case study insight on venture capital investment, life sciences business development, and startup strategy. This session features Kalyan Handique, Chief Executive Officer at Akadeum Life Sciences, Inc. and David Esposito, Chief Executive Officer at ONL Therapeutics. Kalyan brings nearly two decades of experience across life sciences commercialization, business development, and investment sourcing as a serial entrepreneur committed to advancing the Michigan biotech ecosystem. David brings over 3 decades of experience spanning life sciences commercialization, business development, and VC strategy. Together, they will share invaluable insights from their extensive leadership journeys. FYI: By attending the full series, you are accessing the opportunity to engage in the MBVF Innovation Fellowship, a 6-month program in which you will build hands-on experience in biotech ecosystem landscaping and sourcing new technologies.